Find a Pediatric Clinical Trial

Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our list of clinical trials that are currently enrolling new pediatric patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

Showing 61 - 80 of 91 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055]
O'Reilly, Richard
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLA-Compatible Donor
[Protocol 12-053]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
  • Hematology
    • Hematologic Disorders
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders
[Protocol 10-050]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Multiple Myeloma
    • Myelodysplastic Syndrome
  • Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
[Protocol 00-069]
Offit, Kenneth
  • Hereditary Cancer & Genetics
  • Leukemia
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
Analysis of Blood and Salivary Samples for Genetic Studies of Familial Cancers
[Protocol 93-102]
Offit, Kenneth
  • Hereditary Cancer & Genetics
A Study of Salvage Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of High-Risk or Relapsed Hodgkin's Lymphoma
[Protocol 07-147]
Perales, Miguel-Angel
  • Blood & Marrow Stem Cell Transplantation
    • Sibling and Unrelated Volunteer
  • Lymphoma
    • Hodgkin's Disease
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations
[Protocol 11-198]
Pratilas, Christine
  • Melanoma
A Phase I/IIA Study of Dabrafenib in Children with Advanced BRAF Mutation-Positive Solid Tumors
[Protocol 13-016]
Pratilas, Christine
  • Melanoma
  • Pediatric Brain Tumors
  • Solid Tumors
Expanded Access of Prochymal Infusion for the Treatment of Pediatric Patients with Acute Refractory GVHD
[Protocol 09-072]
Prockop, Susan
  • Blood and Marrow Transplantation
    • Transplantation
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 12-116]
Roberts, Stephen
  • Neuroblastoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
A Study of Allogeneic Stem Cell Transplantation in HIV-Infected Patients with Hematologic Cancers
[Protocol 12-092]
Sauter, Craig
  • Blood and Marrow Transplantation
    • Transplantation
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
A Phase II Study of Dasatinib in Children and Adolescents Newly Diagnosed with Chronic Phase CML or with Philadelphia Chromosome-Positive Leukemias Resistant to or Intolerant of Imatinib
[Protocol 11-030]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Chronic Myelocytic Leukemia
Treatment of Patients with Newly Diagnosed Standard Risk B-precursor Acute Lymphoblastic Leukemia
[Protocol 11-002]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
ALTE03N1: Key Adverse Events Following Childhood Cancer
[Protocol 05-070]
Sklar, Charles
  • Survivorship
A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients with Non-Progressive Diffuse Pontine Gliomas Previously Treated with Radiation Therapy
[Protocol 11-011]
Souweidane, Mark
  • Pediatric Brain Tumors
    • Brain Cancer
Evaluating the Causes of Cancer in Young Patients
[Protocol 09-068]
Stadler, Zsofia
  • Breast Cancer
  • Colorectal Cancer
    • Colon Cancer
    • Rectal Cancer
  • Germ Cell Tumors
  • Hereditary Cancer & Genetics
  • Neuroblastoma
  • Primary Bone
    • Osteosarcoma
  • Sarcomas
    • Osteosarcoma
A Phase II Study of Sorafenib in Children and Young Adults with Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, or Papillary Thyroid Cancer
[Protocol 12-139]
Trippett, Tanya
  • Hepatobiliary
    • Liver Cancer
  • Kidney Cancer
  • Sarcomas
    • Rhabdomyosarcoma
  • Thyroid Cancer
A Phase I Study of Blinatumomab in Children and Adolescents with Relapsed/Refractory Acute Lymphoblastic Leukemia
[Protocol 12-044]
Trippett, Tanya
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
[Protocol 11-210]
Trippett, Tanya
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma